Relation between atrial fibrillatory rate and markers of inflammation and haemostasis in persistent human atrial fibrillation.
Tveit
Arnljot
A
Bollmann
Andreas
A
Seljeflot
Ingebjørg
I
Husser
Daniela
D
Stridh
Martin
M
Sörnmo
Leif
L
Arnesen
Harald
H
Olsson
S Bertil
SB
Smith
Pål
P
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000097:blood* / Q000276:immunology* / Q000517:prevention & control; D001562:Benzimidazoles / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood*; D001713:Biphenyl Compounds; D004562:Electrocardiography; D006487:Hemostasis; D006801:Humans; D007249:Inflammation / Q000097:blood; D013777:Tetrazoles / Q000627:therapeutic use
D000959:Antihypertensive Agents; D001562:Benzimidazoles; D015415:Biomarkers; D001713:Biphenyl Compounds; D013777:Tetrazoles; C081643:candesartan